Recipharm Annual Report 2006
Recipharm Annual Report 2006
Recipharm Annual Report 2006
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
CONSOLIDATED<br />
BALANCE SHEETS<br />
EQUITY AND LIABILITIES<br />
Equity<br />
Note 31 Dec <strong>2006</strong> 31 Dec 2005<br />
19<br />
Restricted equity<br />
Share capital (10,000,000 shares) 10,000,000 10,000,000<br />
Restricted reserves 79,903,072 53,645,786<br />
89,903,072 63,645,786<br />
Non-restricted equity<br />
Non-restricted reserves 65,906,144 62,047,040<br />
Net profit/loss for the year 71,242,041 49,174,576<br />
137,148,185 111,221,616<br />
Total equity 227,051,257 174,867,402<br />
Provisions<br />
Deferred income tax liabilities<br />
30,287,862 20,076,695<br />
Total provisions 30,287,862 20,076,695<br />
Long-term liabilities<br />
21<br />
Liabilities to credit institutions 149,552,234 63,566,666<br />
Other long-term liabilities 20,227,304 8,157,796<br />
Total long-term liabilities 169,779,538 71,724,462<br />
Current liabilities<br />
Overdraft facility (credit limit 75 MSEK (75<br />
MSEK))<br />
18 21,227,759 62,958,329<br />
Accounts payable - trade 184,269,597 119,901,412<br />
Liabilities with Parent Company 0 23,333,332<br />
Income tax liabilities 134,177 0<br />
Other current liabilities 118,677,715 23,503,194<br />
Accrued expenses and deferred income 22 46,723,837 82,041,613<br />
Total current liabilities 371,033,085 311,737,880<br />
TOTAL EQUITY AND LIABILITIES 798,151,742 578,406,439<br />
Pledged assets 24 117,400,000 117,400,000<br />
Contingent liabilities None None
Change language